
94% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
CORRECTION article
Front. Immunol. , 03 January 2023
Sec. Vaccines and Molecular Therapeutics
Volume 13 - 2022 | https://doi.org/10.3389/fimmu.2022.1104661
This article is part of the Research Topic Advances in T cell Therapeutic Vaccines for HIV View all 6 articles
This article is a correction to:
Reliable Estimation of CD8 T Cell Inhibition of In Vitro HIV-1 Replication
A corrigendum on
Reliable estimation of CD8 T cell inhibition of in vitro HIV-1 replication
by Xu Y, Weideman AM, Abad-Fernandez M, Mollan KR, Kallon S, Samir S, Warren JA, Clutton G, Roan NR, Adimora AA, Archin N, Kuruc J, Gay C, Hudgens MG and Goonetilleke N (2021) . 12:666991. doi: 10.3389/fimmu.2021.666991
In the published article, an author name was incorrectly written as Nadia Roan. The correct spelling is Nadia R. Roan.
In the published article, an author name was incorrectly written as Cindy Gay. The correct spelling is Cynthia Gay.
The authors apologize for these errors and state that they do not change the scientific conclusions of the article in any way. The original article has been updated.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: HIV, VIA, p24, JRCSF, ROC, CD8, CD4, T-cell
Citation: Xu Y, Weideman AM, Abad-Fernandez M, Mollan KR, Kallon S, Samir S, Warren JA, Clutton G, Roan NR, Adimora AA, Archin N, Kuruc J, Gay C, Hudgens MG and Goonetilleke N (2023) Corrigendum: Reliable estimation of CD8 T cell inhibition of in vitro HIV-1 replication. Front. Immunol. 13:1104661. doi: 10.3389/fimmu.2022.1104661
Received: 21 November 2022; Accepted: 22 November 2022;
Published: 03 January 2023.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2023 Xu, Weideman, Abad-Fernandez, Mollan, Kallon, Samir, Warren, Clutton, Roan, Adimora, Archin, Kuruc, Gay, Hudgens and Goonetilleke. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Nilu Goonetilleke, bmlsdV9nb29uZXRpbGxla2VAbWVkLnVuYy5lZHU=
†These authors have contributed equally to this work
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Research integrity at Frontiers
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.